Page last updated: 2024-09-04

glucagon and 1-(3-chlorophenyl)piperazine

glucagon has been researched along with 1-(3-chlorophenyl)piperazine in 1 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(1-(3-chlorophenyl)piperazine)
Trials
(1-(3-chlorophenyl)piperazine)
Recent Studies (post-2010) (1-(3-chlorophenyl)piperazine)
26,0391,4983,05483314287

Protein Interaction Comparison

ProteinTaxonomyglucagon (IC50)1-(3-chlorophenyl)piperazine (IC50)
Beta-1 adrenergic receptorHomo sapiens (human)2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sugimoto, Y; Yamada, J1

Other Studies

1 other study(ies) available for glucagon and 1-(3-chlorophenyl)piperazine

ArticleYear
The 5-HT(2C/2B) receptor agonist, m-chlorophenylpiperazine, increases plasma glucagon levels in rats.
    European journal of pharmacology, 2000, Oct-06, Volume: 406, Issue:1

    Topics: Adrenal Medulla; Animals; Blood Glucose; Dose-Response Relationship, Drug; Glucagon; Ketanserin; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors

2000